2013 Emerald Groundhog Day Investment Forum Public Company Presenters are scheduled to include:

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)Ametek Inc. (NYSE: AME)Aqua America Inc. (NYSE: WTR)Black Box Corp. (NASDAQ: BBOX)Bryn Mawr Bank Corp. (NASDAQ: BMTC)Crown Holdings, Inc. (NYSE: CCK)EPAM Systems, Inc. (NASDAQ: EPAM)FARO Technologies Inc. (NASDAQ: FARO)First Commonwealth Financial Corp (NYSE: FCF)GSV Capital Corp (NASDAQ: GSVC)Howard Bancorp. Inc. (NASDAQ: HBMD)Matthews International Corp. (NASDAQ: MATW)Nexstar Broadcasting Group, Inc. (NASDAQ: NXST)Old Line Bancshares, Inc. (NASDAQ: OLBK)PhotoMedex, Inc. (NASDAQ: PHMD)Quaker Chemical Corp. (NYSE: KWR)Safeguard Scientifics, Inc. (NYSE: SFE)Sandy Spring Bancorp (NASDAQ: SASR)Sarepta Therapeutics, Inc. (NASDAQ: SRPT)Sinclair Broadcast Group, Inc. (NASDAQ: SBGI)Teche Holding Company (NYSE: TSH)Toll Brothers, Inc. (NYSE: TOL)Trex Co., Inc. (NASDAQ: TREX)Wisdom Tree Investments, Inc. (NASDAQ: WETF)

Additional information on the Forum, including registration information, can be found at http://www.teamemerald.com/groundhog .

Founded in 1991, Emerald Asset Management, Inc. is a diversified investment management company that operates thru its wholly-owned subsidiaries Emerald Advisers, Inc. and Emerald Mutual Fund Advisers Trust. Emerald Advisers and PMG jointly own Emerald Fixed Income Advisers, LLC. Assets managed by these companies totaled over $2 billion as of December 31, 2012. “Driven by Research,” Emerald employs an intense fundamental, research-focused investment philosophy and focuses primarily on growth-oriented equity investing and high-quality disciplined fixed-income investing. Emerald is headquartered in Leola, Pennsylvania and operates satellite offices in King of Prussia, Pennsylvania and Pittsburgh, Pennsylvania.

Emerald Asset Management, Inc.Emerald Advisers, Inc.Emerald Fixed Income Advisers LLCEmerald Mutual Fund Advisers TrustEmerald Separate Account Management LLC3175 Oregon PikeLeola, PA 17540717.556.8900800.722.4123 www.TeamEmerald.com

Copyright Business Wire 2010

If you liked this article you might like

Alnylam Shares Skyrocket on Clinical Study Results - Biotech Movers

Intra-Cellular Leaps; Schizophrenia Drug Shows Less Side Effects-Biotech Movers

Tesla's Rally Has Died: Stock Falls to Sixth Worst Performer in Russell 1000

Biotech Movers: Inovio, Neurocrine, Alnylam

Biotech Movers: Ionis, Alnylam, Amicus, Minerva